{
  "id": "6aa44cab5879938d",
  "title": "STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?",
  "description": "A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.",
  "content": "A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/11/hims-federal-scrutiny-impact-on-telehealth-compounding-pharmacies/?utm_campaign=rss",
  "published_at": "2026-02-11T09:30:00+00:00",
  "fetched_at": "2026-02-12T00:28:38.246764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "regulatory"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?",
    "description": "A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.",
    "url": "https://www.statnews.com/2026/02/11/hims-federal-scrutiny-impact-on-telehealth-compounding-pharmacies/?utm_campaign=rss",
    "published": "2026-02-11T09:30:00+00:00",
    "source": "STAT"
  }
}